滕红刚博士自 2024 年 3 月起担任辽宁依生总经理，并兼任湖岸生物生产制造管理部负责人。滕博士在生物医药领域拥有超过 20 年的丰富经验，专注于单克隆抗体、HAV 和 HBV 疫苗、HPV 疫苗、狂犬病疫苗以及 HIV/AIDS DNA 疫苗等项目的研发与制造。在此之前，他曾担任江苏金迪克生物技术股份有限公司副总经理，全面负责公司的生产、研发工作。2016 年 8 月至 2022 年 3 月，滕博士担任辽宁依生副总经理；2016 年 8 月至 2018 年 11 月，他同时担任辽宁依生生产及质量管理部负责人。加入本公司之前，滕博士于 2012 年 1 月至 2015 年 6 月担任长春卫尔赛生物药业有限公司生产总监，并于 2007 年 6 月至 2009 年 6 月担任吉林亚泰生物药业股份有限公司副总经理。

滕博士于 1995 年 7 月获得吉林大学生物化学学士学位，2006 年 7 月获得吉林大学生命科学学院生物化学与分子生物学专业博士学位。

Head of Production and Quality Management

Dr. Honggang Teng has served as general manager and head of production and quality management of Liaoning Yisheng since March 2024. Dr. Teng has over 20 years of R&D and manufacturing experience in monoclonal antibodies, HAV and HBV vaccines, HPV vaccine, rabies vaccine, and HIV/AIDS DNA vaccine programs.

Prior to that, he served as vice president of Jiangsu JDK Biotechnology Company Limited and was responsible for overseeing the company’s manufacturing and research & development functions. From August 2016 to March 2022, he served as vice president of Liaoning Yisheng, concurrently acting as head of production and quality management from August 2016 to November 2018.

Prior to joining us, Dr. Teng served as the production director in Chuangchun Zhuoyi Biological Co., Ltd from January 2012 to June 2015. From June 2007 to June 2009, he served as the general manager assistant and vice general manager in Yatai Bio-Pharmaceuticals Co., Ltd.

Dr. Teng obtained his Ph.D. in Biochemistry and Molecular Biology from the School of Life Sciences, Jilin University, in July 2006, and his Bachelor’s degree in Biochemistry from Jilin University in July 1995.